To assess the role of germline pathogenic variants (PVs) in SMARCA4 and further established OC predisposition genes in early onset OC, we investigated a clinical cohort of 206 unrelated index patients using an extended panel of 25 (candidate) cancer predisposition genes. This evidence concerns the gene SMARCA4 and cancer.